Indegene Limited IPO

Founded in 1998, Indegene Limited provides digital services for the life sciences industry. They assist with drug development, clinical trials, regulatory submissions, pharmacovigilance, complaints management

and sales/marketing support.

The company’s services can be divided into following categories

  1. Enterprise Commercial Solutions
  2. Omnichannel Activation
  3. Enterprise Medical Solutions
  4. Enterprise Clinical Solutions and consultancy services

The subsidiary of the company, DT Associates Limited, provides consulting services under the “DT Consulting” brand. It helps life sciences companies manage their digital transformation efforts to ensure continued success in customer experience.

The company received the Platinum Level award at the 2023 Healthy Workplace Conference and Awards, a recognition given by Arogya World India Trust in partnership with the Public Health Foundation of India.

As of December 31, 2023, the company had 65 clients actively engaged with its services.

As of December 31, 2023, the company employed 5,181 people worldwide. Of these, 4,461 are based in India, 530 work in North America, 105 in Europe, 73 in China, and 12 in other regions.

Indegene Limited Financial Information (Restated Consolidated)

Indegene Limited’s revenue increased by 39.85% and profit after tax (PAT) rose by 63.43% between the financial year ending with March 31, 2023 and March 31, 2022.

Period Ended31 Dec 202331 Mar 202331 Mar 202231 Mar 2021
Assets2,518.152,203.871,353.47596.04
Revenue1,969.752,364.101,690.50996.92
Profit After Tax241.90266.10162.82149.41
Net Worth1,327.001,063.72763.90324.51
Reserves and Surplus1,282.651,019.43763.55324.19
Total Borrowing399.33394.3418.2424.76
Amount in ₹ Crore

Objects of the Issue (Indegene IPO Objectives)

The Company proposes to utilise the Net Proceeds towards funding the following objects:

  1. Repayment/prepayment of indebtedness of one of the Material Subsidiaries, ILSL Holdings, Inc.;
  2. Funding the capital expenditure requirements of the Company and one of the Material Subsidiaries, Indegene, Inc.; and
  3. General corporate purposes and inorganic growth.

Indegene IPO Timeline (Tentative Schedule)

Indegene IPO opens on May 6, 2024, and closes on May 8, 2024.

IPO Open DateMonday, May 6, 2024
IPO Close DateWednesday, May 8, 2024
Basis of AllotmentThursday, May 9, 2024
Initiation of RefundsFriday, May 10, 2024
Credit of Shares to DematFriday, May 10, 2024
Listing DateMonday, May 13, 2024
Cut-off time for UPI mandate confirmation5 PM on May 8, 2024

SHARIAH SCREENING for - Indegene Limited IPO

BUSINESS SCREEN

FINANCIAL RATIOS

As per our analysis and Based on the information we have, this is the output.
Allah knows best.
If you find this result mistaken or questionable, let us know via email at info (@) halalstock.in

Spread the Knowledge - Share the Latest IPO Updates and Shariah Compliant IPO's.

Latest Current & Upcoming IPOs in BSE & NSE - Including Shariah Compliant.

The IPO dashboard offers insights on the Latest Current & Upcoming IPOs in BSE & NSE. It also evaluates IPOs for Shariah compliance, ensuring alignment with Islamic principles for ethical investment choices.

IPO

Rulka Electricals Limited IPO Detail

Last Updated on May 14, 2024 Rulka Electricals Limited IPO Founded in May 2013, Rulka Electricals Limited is an electrical and Fire-Fighting solutions company. The company offers various services, including

Read More »

Dear Halal Stock Users,

If you believe our website is a valuable resource,
we invite you to support us.
Your contribution ensures free access for all
and fuels future development.

You can contribute as little as
100, 200, 500 & so…
every bit counts.

Thank you for your support!